Rabbit Polyclonal TBC1D9B antibody. C-terminal. Suitable for IP, WB and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human TBC1D9B aa 1200 to C-terminus.
pH: 7 - 8
Preservative: 0.09% Sodium azide
Constituents: 99% Tris citrate/phosphate
IP | WB | |
---|---|---|
Human | Tested | Tested |
Chimpanzee | Predicted | Predicted |
Gorilla | Predicted | Predicted |
Orangutan | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 2.00000-10.00000 µg/mg of lysate | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Chimpanzee, Gorilla, Orangutan | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/2000.00000 - 1/10000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Chimpanzee, Gorilla, Orangutan | Dilution info - | Notes - |
Select an associated product type
May act as a GTPase-activating protein for Rab family protein(s).
KIAA0676, TBC1D9B, TBC1 domain family member 9B
Rabbit Polyclonal TBC1D9B antibody. C-terminal. Suitable for IP, WB and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human TBC1D9B aa 1200 to C-terminus.
pH: 7 - 8
Preservative: 0.09% Sodium azide
Constituents: 99% Tris citrate/phosphate
Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.
If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.
Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.
TBC1D9B also known as TBC domain family member 9B is a protein characterized by its role as a GTPase-activating protein for Rab family proteins. It has a molecular mass of approximately 145 kDa. TBC1D9B is expressed widely in human tissues including but not limited to the heart brain and skeletal muscle. This protein interacts with small GTPases regulating their cycle of activation and inactivation which is important for intracellular trafficking processes.
TBC1D9B participates in the regulation of endosomal dynamics and autophagy. This protein is part of the broader Rab GTPase network influencing vesicular transport and membrane fusion events within the cell. In various tissues TBC1D9B modulates cellular functions such as receptor recycling and protein degradation thereby maintaining cellular homeostasis. The protein's role in endosomal transport is particularly important in neurons where it impacts synaptic vesicle cycling.
Several intracellular trafficking pathways engage TBC1D9B. It plays a significant role in the insulin signaling pathway and the endocytic pathway. By interacting with pathways such as these TBC1D9B influences the proper functioning of Rab GTPases notably Rab11. This association is vital for controlling endosomal sorting and recycling processes that are instrumental in various cellular activities like nutrient uptake and signaling cascades linked with cell growth and metabolism.
Certain pathologies demonstrate a connection with TBC1D9B. Alterations in its function have been implicated in diabetes due to the protein's influence on insulin action and glucose regulation. Additionally abnormal activity of TBC1D9B links to neurodegenerative conditions given its critical role in neural trafficking processes. The relationship between TBC1D9B and Rab GTPases like Rab11 underlines its importance in the pathophysiology of these disorders influencing disease progression through impaired vesicular transport.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Lysates prepared using NETN lysis buffer.
All lanes: Western blot - Anti-TBC1D9B antibody - C-terminal (ab200578) at 0.1 µg/mL
Lane 1: HeLa whole cell lysate at 50 µg
Lane 2: 293T whole cell lysate at 50 µg
Lane 3: Jurkat whole cell lysate at 50 µg
Developed using the ECL technique.
Predicted band size: 141 kDa
Exposure time: 3min
Immunoprecipitation analysis of 293T cell lysate (in NETN buffer, 0.5 or 1.0 mg per IP reaction; 20% of IP loaded) labeling TBC1D9B using ab200578 at 6 μg per reaction (lane 1). A Control IgG was used in lane 2. For blotting immunoprecipitated TBC1D9B, ab200578 was used at 1 μg/ml.
All lanes: Immunoprecipitation - Anti-TBC1D9B antibody - C-terminal (ab200578)
Developed using the ECL technique.
Predicted band size: 141 kDa
Exposure time: 30s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com